drugset / Trial / NCT00819845

Ramipril Versus Carvedilol in Duchenne and Becker Patients

NCT00819845

Phase 4 Unknown 194 enrolled Catholic University, Italy
RandomizedParallel-groupOpen-labelPrevention

Summary

Data on preventive therapy in Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) affected individuals without cardiac involvement are very limited and currently lacking regard both ACE-inhibitors and Beta-Blockers in Becker Muscular Dystrophy and for the latter even in Duchenne Muscular Dystrophy patients. Thus, the study aim is to compare the efficacy of carvedilol vs ramipril on myocardial tissue properties and heart function, performing CMR and myocardial Ultrasound Tissue Characterisation analysis.

Timeline

Start
2008-12
Primary completion
2009-06
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvedilol Other / unclassified
Subject Ramipril Small molecule